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Introduction 
The availability of rapid and versatile chemical approaches to 
produce highly functionalized molecules represents an essential 
medicinal chemistry tool for drug-discovery campaigns. Most of 
the new small molecule first-in-class drugs approved in the last 
10 years came in fact from phenotypic screening of compounds’ 
libraries rather than from targeted approaches.
1
 The exploration 
of the chemical space around a privileged scaffold (privileged 
diversity-oriented synthesis; pDOS) is therefore considered an 
efficient strategy to increase the molecular diversity and discover 
new chemical probes for drug discovery.
2 
Among the many 
privileged scaffold identified so far, benzofuran exhibits 
biological activity on a surprisingly high number of targets.
3
 It is 
present in numerous bioactive natural products, polymers and 
pharmaceuticals.
4
 Drugs containing benzofuran rings are in 
clinical use for the treatment of cardiac arrhythmyas 
(Amiodarone, Dronedarone), urinary incontinence (Darifenacin), 
moderate Alzheimer disease (Galantamine), opioids overdose 
(Naloxone, Naltrexone), tubercolosis infections (Rifampicin, 
Rifapentin, Rifabutin), hypertension and heart failure 
(Saprisartan), jet-lag syndrome (Ramelteon).
3
 Benzofurans are 





























 and GSK-3 inhibitors.
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Figure 1. Representative benzofuran-based bioactive compounds 
GPCRs-targeting ligands, like Vilazodone (5-HT1A partial 









 and Adenosine A2A receptors (5)
23
 
(Figure 1). Due to the extraordinary wide range of possible 
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A fast, versatile and practical microwave-assisted multicomponent protocol for the synthesis of 
substituted benzofuran-2-carboxamides has been developed. The present method proved to be 
effective on a series of commercially available amines, 2'-hydroxyacetophenones, aldehydes and 
benzonitriles and could be exploited in drug-discovery campaigns for the rapid identification of 
biologically active hit compounds. 










applications it is not surprising that many efforts have been 
directed at the development of convenient synthetic strategies. 
Common synthetic approaches to substitued benzofurans include 
the modification of various arenes,
4,23-25
 with carbon-oxygen 
bond formation
26-27
 or through transition-metal catalysts.
28-33
 One 
of the most used synthetic strategies, is represented by a three 
step synthesis starting from amines 6  that are reacted with 
chloroacetyl chloride to give the chloroacetamide derivatives 7, 
which are used in the  O-alkylation of o-hydroxy aryl ketones to 





Scheme 1. Reagents and conditions: i. K2CO3, DCM, 0 °C-rt; ii. K2CO3, 
MeCN, reflux; iii. Cs2CO3, DMF, 110 °C. 
These methodologies, although somehow valuable, normally 
require multiple steps/purification and are often affected by 
drawbacks such as long reaction times, low versatility due to 
limited availability of the starting materials and, in some cases, 
the need for expensive transition metal-containing reactants.
25-
26,29 
Such characteristics are not particularly suitable for libraries 
generation in hit/drug discovery campaigns: the ideal synthetic 
approach should be fast, versatile, time and step economic and 
should be suitable, as far as possible, for combinatorial and 
parallel chemistry applications.
35
 As a continuation of our interest 
in the development of microwave-assisted and multicomponent 
strategies for the synthesis of biologically active probes,
36-38
 we 
wanted to develop a new microwave-assisted procedure for the 
synthesis of substituted benzofurans in a one-pot fashion, since 
an efficient multicomponent approach to the synthesis of the 
benzofurans is still elusive. We report herein the first microwave-
assisted one-pot three-component catalyst-free procedure for the 
synthesis of highly functionalized benzofuran-2-carboxamides 
directly from commercially available building blocks in 
extremely short reaction times. 
Results and Discussion 
As reported in Scheme 1, the standard conditions for the 
synthesis of α-halogen carboxamides normally requires that α-
halogenacetyl chloride and an amine react in a polar aprotic 
solvent (like DMF) or in an apolar solvent in presence of a base 
(usually NEt3) at room temperature for hours.
39-43
 We tried to 
speed up the synthesis of 7a by microwave irradiation, heating 6a 
and chloroacetyl chloride at 100 °C in DMF: after 5 minutes the 
reaction was completed and the resulting product 7a was directly 
reacted with 2'-hydroxyacetophenone 8a under the reaction 
conditions reported by Xie et al. (Scheme 2).
44 
A complex 
reaction mixture was obtained and only traces of the product 10a 
(3%) were isolated. Different reaction conditions were then tested 
to optimize the above protocol, changing the  temperatures (50-
150 °C), base (NEt3) and solvents (dioxane, THF, EtOH, DMF), 
but they all gave a mixture with many decomposition products 
and a low amount of the desired compound 10a (<5%). 
 
Scheme 2. Reagents and conditions: i. DMF, µW 100 °C, 5 min; ii. 2'-
hydroxyacetophenone (8a), Cs2CO3, DMF, µW 80 °C, 30 min; iii. Cs2CO3, 
DMF, µW 140 °C, 30 min 
At the end of the irradiation cycle, some unreacted 2'-
hydroxyacetophenone 8a was always detected. This, together 
with the hypothesized reaction mechanism (Figure 2) let us to 
speculate that the limiting step in the synthetic sequence was the 
O-alkylation. In order to speed-up this step, more reactive acetyl 
chlorides were tested (α-bromo- and α-iodoacetyl chlorides): also 
in this case, 10a was formed only in traces (7 and 4 % 
respectively), probably because the more reactive α-bromo and α-
iodo intermediates are also more prone to decomposition under 
our reaction conditions. The addition of a catalytic amount of 
iodide (in the form of KI or TBAI) to activate the α-chloroacetyl 
chloride,
41-42,45






































Figure 2. Hypothesized reaction mechanism. 
As a practical observation, we noticed that at room 
temperature in dry DMF, without the addition of any base, the 
reaction between aniline 6a and α-chloroacetyl chloride was 
occurring even in the presence of the 2'-hydroxyacetophenone. 
At this point, due to the high reactivity of the involved 
intermediates, we decided to combine all the building blocks 
(aniline, α-chloroacetyl chloride and 2'-hydroxyacetophenone) in 
a multicomponent fashion, using different solvents, bases, 
temperatures, and irradiation times (Table 1). As shown by the 
results summarized in Table 1, the desired benzofuran derivative 
10a was already obtained at 80 °C after 5 minutes of irradiation 
(Table 1, Entry 1) and its yield was increased with longer 
reactions times (Table 1, Entries 2-3). Higher reaction 
temperatures, up to 140 
o
C, allowed to reduce the irradiation time 
and also to increase the yields (Table 1, Entries 4-6). However, 
rising the temperature over 140 
o
C caused substantial 
decomposition and reduced yield of 10a (Table 1, Entry 7). 
Using different solvents (EtOH, H2O, THF, dioxane) (Table 1, 
Entry 9,10, 11, 12, 13) or a different base (K2CO3, Et3N) (Table 1, 
Entry 8,10,14) caused a drastic drop in the yields. 
  
 3 
Table 1. Optimization of the multicomponent protocol 
In summary, the optimal reaction conditions for the 
microwave-assisted multicomponent synthesis of benzofuran-2-
carboxamides required the addition of anilines, α-chloroacetyl 
chloride and 2'-hydroxyacetophenones at 0 °C in dry DMF and 
subsequent irradiation at 140 °C for 5 minutes, in presence of 
Cs2CO3 as a base (Table 1, Entry 6). To verify the versatility and 
efficiency of the optimized microwave-assisted multicomponent 
protocol, a series of commercially available 2'-
hydroxyacetophenones (8a-d) or benzaldehyde (8e) or 
benzonitrile (8f), α-chloroacetyl chloride and amines (6a-j) were 
used as building blocks to quickly generate a small collection of 
functionalized benzofuran-2-carboxamides 10a-o (Table 2).  
From the results reported in Table 2 it is possible to observe 
that electron-donating substituents on the o-
hydroxyacetophenone ring (Entries 9-11) cause a drop of yield 
(products 10i-k) compared to unsubstituted 2'-
hydroxyacetophenones (Entry 1, product 10a), probably because 
they deactivate the ketone moiety disfavoring the intramolecular 
cyclization. Salicylaldehyde (8e) or 2-hydroxybenzonitrile (8f) 
can also be used in place of 2'-hydroxyacetophenones 8a-d, 
giving benzofuran-2-carboxamides (10n,o; Entries 14-15) with a 
different substituent in position C3 (R5 = H, NH2). Strong para 
electron-withdrawing groups on the aniline (Entries 4,6) led to 
low yields of the corresponding benzofurans 10d,f: this effect is 
probably due to a competing deprotonation of the NH-proton 
rather than the α-position of the amide intermediate 9 before 
heterocyclization. Mild para electron-donating substituents on 
the aniline slightly increase the reaction yields (Entry 5), while 
meta electron-withdrawing groups cause a drop in the yields 
(Entries 7-8). Strong electron-donating substituents cause an 
increase in the yields (Entry 12). Secondary amines are also well 
tolerated and gave the corresponding benzofuran-2-carboxamides 
in good yields (Entry 2). Aliphatic amines (e.g. morpholine) also 
gave the desired product 10m after a little longer reaction time 
(Entry 13).  
 
 
Table 2. Microwave-assisted multicomponent synthesis of benzofuran-2-
carboxamides 10a-o 
Conclusions 
In conclusion we have developed a practical, versatile, fast 
and transition metal-free microwave-assisted multicomponent 
procedure for the synthesis of benzofuran-2-carboxamides 
starting from commercially available and cheap building blocks. 
This methodology allowed us to generate highly functionalized 
3-alkylbenzofurans (Entries 1-13), 3-aminobenzofurans (Entry 
15) and 3-unsubstituted benzofurans (Entry 14) in a short 
reaction time and acceptable yields.  Further exploitation of the 
approach herein reported may allow to quickly generate libraries 
of substituted benzofurans for drug-discovery campaigns. 
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1 DMF Cs2CO3 80 5 16 
2 DMF Cs2CO3 80 15 20 
3 DMF Cs2CO3 80 30 32 
4 DMF Cs2CO3 100 5 24 
5 DMF Cs2CO3 120 5 35 
6 DMF Cs2CO3 140 5 43 
7 DMF Cs2CO3 160 5 15 
8 DMF K2CO3 140 5 22 
9 EtOH Cs2CO3 140
 
5 18 
10 EtOH K2CO3 140 5 13 
11 H2O Cs2CO3 140 5 9 
12 THF Cs2CO3 140 5 17 
13 Dioxane Cs2CO3 140 5 15 
14 DMF NEt3 140 5 26 
a
isolated yield     
 





1 10a Ph H H H Me 43 
2 10b Ph Ph H H Me 45 
3 10c 4-ClPh H H H Me 59 
4 10d 4-NO2Ph H H H Me 25 
5 10e 4-i-PrPh H H H Me 44 
6 10f 4-CF3Ph H H H Me 27 
7 10g 3-FPh H H H Me 20 
8 10h 3-ClPh H H H Me 25 
9 10i Ph H Me H Me 18 
10 10j Ph H OMe H Me 15 
11 10k Ph H H OMe Me 19 
12 10l 3-OMePh H H H Me 51 
13 10m 
 
H H Me 35
b 
14 10n Ph H H H H 38 
15 10o Ph H H H NH2 33 
a
isolated yield after flash chromatography; 
b
reaction time :10 minutes 
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- Microwave-assisted synthesis of highly 
functionalized benzofuran-2-carboxamides. 
- Compounds are obtained in a one-pot 
multicomponent reaction after 5 minutes. 
- A simple and versatile metal-free approach 
incorporating commercial synthons. 
 
